Answer
Jun 23, 2026 - 12:13 PM
As of June 23, 2026, Retatrutide has no official release date. Eli Lilly says it is still investigational, in Phase 3 trials, and not FDA-approved or available for public use; Lilly states launch depends on trial completion and regulatory approval.
The best current expectation is:
Likely U.S. availability: sometime in 2027, if FDA review and approval go smoothly. Reuters reported in May 2026 that Lilly aims to potentially launch retatrutide next year after key Phase 3 data supported seeking regulatory approval.
Do you have the same question? Follow this Question
Jun 23, 2026 - 12:13 PM
View all Retatrutide Questions & Answers